NCT00540358 - A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

June 30, 2010

Conditions

Breast Cancer

Interventions

DRUG

gemcitabine/carboplatin

Gemcitabine and carboplatin administered according to instructions in the package inserts.

DRUG

iniparib

"Body weight adjusted dose~1 hour intravenous infusion"

Trial Locations (18)

Research Site, Birmingham

Research Site, Denver

Research Site, Torrington

Research Site, Ocoee

Research Site, Indianapolis

Research Site, Overland Park

Research Site, Henderson

Research Site, Hooksett

Research Site, Raleigh

Research Site, Bedford

Research Site, Dallas

Research Site, El Paso

Research Site, Fort Worth

Research Site, Houston

Research Site, Tyler

Research Site, Fairfax

Research Site, Vancouver

Research Site, Yakima